• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    UGI Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

    5/8/25 8:33:49 AM ET
    $UGI
    Natural Gas Distribution
    Utilities
    Get the next $UGI alert in real time by email
    ugi-20250507
    0000884614false00008846142025-05-072025-05-07

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    WASHINGTON, D.C. 20549
     
     
    FORM 8-K
     
    CURRENT REPORT
    Pursuant to Section 13 or 15(d)
    of The Securities Exchange Act of 1934
    Date of Report (Date of earliest event reported): May 7, 2025
      
    UGI Corporation
    (Exact Name of Registrant as Specified in Its Charter)
     
    Pennsylvania1-1107123-2668356
    (State or Other Jurisdiction
    of Incorporation)
    (Commission
    File Number)
    (IRS Employer
    Identification No.)

    500 North Gulph Road, King of Prussia, PA 19406
    (Address of Principal Executive Offices) (Zip Code)

    Registrant’s Telephone Number, Including Area Code: 610 337-1000
    Not Applicable
    Former Name or Former Address, if Changed Since Last Report

     
    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
    ☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    ☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    ☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    ☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

    Securities registered pursuant to Section 12(b) of the Act:
    Title of each class
    Trading Symbol(s)
    Name of each exchange on which registered
    Common Stock, without par value
    UGI
    New York Stock Exchange
    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
    Emerging growth company☐
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐



    Item 2.02 Results of Operations and Financial Condition.
    On May 7, 2025, UGI Corporation (the “Company”) issued a press release announcing financial results for the Company for the fiscal quarter ended March 31, 2025. A copy of the press release is furnished as Exhibit 99.1 to this report and is incorporated herein by reference.
    Item 7.01 Regulation FD Disclosure.
    On May 8, 2025, the Company will hold a live Internet Audio Webcast of its conference call to discuss its financial results for the fiscal quarter ended March 31, 2025.
    Presentation materials containing certain historical and forward-looking information relating to the Company (the “Presentation Materials”) have been made available on the Company’s website. A copy of the Presentation Materials is furnished as Exhibit 99.2 to this report and is incorporated herein by reference in this Item 7.01. All information in Exhibit 99.2 is presented as of the particular dates referenced therein, and the Company does not undertake any obligation to, and disclaims any duty to, update any of the information provided.
    In accordance with General Instruction B.2 of Form 8-K, the information in this report, including Exhibits 99.1 and 99.2, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, and will not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in that filing.
    Item 9.01 Financial Statements and Exhibits.
    (d) Exhibits. The following exhibits are being furnished herewith:
     
    99.1
    Press Release of UGI Corporation dated May 7, 2025.
    99.2
    Presentation of UGI Corporation dated May 8, 2025.
    104Cover Page Interactive Data File (formatted as inline XBRL)




    SIGNATURES
    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
     
    UGI Corporation
    May 8, 2025By:/s/ Sean P. O'Brien
    Name:Sean P. O'Brien
    Title:Chief Financial Officer



    Get the next $UGI alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $UGI

    DatePrice TargetRatingAnalyst
    11/22/2024$28.00Buy
    Jefferies
    11/15/2024$27.00 → $30.00Neutral → Outperform
    Mizuho
    3/14/2024$27.00 → $28.00Overweight → Equal Weight
    Wells Fargo
    8/28/2023$28.00 → $27.00Equal Weight → Overweight
    Wells Fargo
    4/26/2023$38.00Neutral
    Mizuho
    1/18/2023$36.00 → $39.00Equal Weight → Underweight
    Barclays
    11/23/2022$43.00 → $41.00Neutral → Underperform
    BofA Securities
    3/7/2022$46.00 → $38.00Buy → Neutral
    B of A Securities
    More analyst ratings